INFLIXIMAB

infliximab 120 mg/mL injection, 1 mL pen device

INFLIXIMAB (13054C)

infliximab 120 mg/mL injection, 1 mL pen device
13054C
Body System:
Manner of administration:Injection
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17531)

Indication: Severe psoriatic arthritis
Treatment phase: Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $578.68 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Remsima SC